Table 5.
Outcome
| Parameter | STEMI | NSTEMI | P Value |
|---|---|---|---|
| Intraoperative mortality | 1 (0.3) | 1 (0.2) | 1.000 |
| 30‐d mortality | 8 (2.7) | 30 (6.6) | 0.018 |
| Time to surgery and 30‐d mortality | |||
| ≤6 h to surgery | 3 (1.8) | 7 (7.1) | 0.041 |
| 6–12 h to surgery | 4 (6.1) | 7 (5.5) | 1.000 |
| 12–48 h to surgery | 1 (1.8) | 16 (7.1) | 0.210 |
| NSTEMI <6 h (n=95) | NSTEMI ≥6 h (n=366) | ||
| Preoperative lactate, mmol/L | 1.15 (0.88–1.50) | 1.00 (0.88–1.30) | 0.019 |
| Lactate >2 mmol/L | 16 (16.9) | 30 (8.2) | 0.020 |
| Acetylsalicylic acid and clopidogrel | 14 (14.7) | 138 (37.7) | 0.007 |
| Preoperative IABP | 13 (13.7) | 16 (4.4) | 0.003 |
| STEMI <6 h (n=171) | STEMI ≥6 h (n=134) | ||
| CK‐MB U/L | 54 (19.5–101.5) | 78.5 (40.1–163.5) | 0.001 |
Values are expressed as count (percentage) or median (range). CK‐MB indicates creatine kinase‐MB; IABP, intra‐aortic‐balloon pump; NSTEMI, non–ST‐segment–elevation myocardial infarction; STEMI, ST‐segment–elevation myocardial infarction.